These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16426043)

  • 41. Consensus features of CP-MLR and GA in modeling HIV-1 RT inhibitory activity of 4-benzyl/benzoylpyridin-2-one analogues.
    Deshpande S; Singh R; Goodarzi M; Katti SB; Prabhakar YS
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):696-705. PubMed ID: 21284408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploration of linear modelling techniques and their combination with multivariate adaptive regression splines to predict gastro-intestinal absorption of drugs.
    Deconinck E; Coomans D; Vander Heyden Y
    J Pharm Biomed Anal; 2007 Jan; 43(1):119-30. PubMed ID: 16859855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quinoxalinones Based Aldose Reductase Inhibitors: 2D and 3D-QSAR Analysis.
    Masand VH; Elsayed NN; Thakur SD; Gawhale N; Rathore MM
    Mol Inform; 2019 Aug; 38(8-9):e1800149. PubMed ID: 31131980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors.
    Hu L; Chen G; Chau RM
    J Mol Graph Model; 2006 Jan; 24(4):244-53. PubMed ID: 16226911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. QSAR study of angiotensin II antagonists using robust boosting partial least squares regression.
    Zhou YP; Cai CB; Huan S; Jiang JH; Wu HL; Shen GL; Yu RQ
    Anal Chim Acta; 2007 Jun; 593(1):68-74. PubMed ID: 17531825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modelling of serotonin reuptake inhibitory and histamine H₃antagonistic activity of piperazine and diazepane amides: QSAR rationales for co-optimization of the activity profiles.
    Sharma BK; Singh P; Shekhawat M; Sarbhai K; Prabhakar YS
    SAR QSAR Environ Res; 2011 Jun; 22(3):365-83. PubMed ID: 21598199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
    Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
    Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combinatorial QSAR modeling of P-glycoprotein substrates.
    de Cerqueira Lima P; Golbraikh A; Oloff S; Xiao Y; Tropsha A
    J Chem Inf Model; 2006; 46(3):1245-54. PubMed ID: 16711744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring structural requirements for aldose-reductase inhibition by 2,4-dioxo-5-(naphth-2-ylmethylene)-3-thiazolidinyl acetic acids and 2-thioxo analogues: Fujita-Ban and Hansch approach.
    Soni LK; Kaskhedikar SG
    Arch Pharm (Weinheim); 2006 Jun; 339(6):327-31. PubMed ID: 16622827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative structure-lambda(max) relationship study on flavones by heuristic method and radial basis function neural network.
    Liu H; Wen Y; Luan F; Gao Y; Li X
    Anal Chim Acta; 2009 Sep; 649(1):52-61. PubMed ID: 19664462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. QSAR and SAR studies on the reduction of some aromatic nitro compounds by xanthine oxidase.
    Thakur M; Thakur A; Balasubramanian K
    J Chem Inf Model; 2006; 46(1):103-10. PubMed ID: 16426045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A quantitative structure-activity relationship study on serotonin 5-HT6) receptor ligands: indolyl and piperidinyl sulphonamides.
    Sharma BK; Singh P; Sarbhai K; Prabhakar YS
    SAR QSAR Environ Res; 2010 Apr; 21(3-4):369-88. PubMed ID: 20544556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors.
    Roy K; Roy PP
    Chem Biol Drug Des; 2008 Nov; 72(5):370-82. PubMed ID: 19012573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. QSAR analysis of substituted bis[(acridine-4-carboxamide)propyl]methylamines using optimized block-wise variable combination by particle swarm optimization for partial least squares modeling.
    Lin L; Lin WQ; Jiang JH; Shen GL; Yu RQ
    Eur J Pharm Sci; 2005 Jun; 25(2-3):245-54. PubMed ID: 15911220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of gas chromatography/electron capture detector retention times of chlorinated pesticides, herbicides, and organohalides by multivariate chemometrics methods.
    Ghasemi J; Asadpour S; Abdolmaleki A
    Anal Chim Acta; 2007 Apr; 588(2):200-6. PubMed ID: 17386811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Artificial neural networks-based approach to design ARIs using QSAR for diabetes mellitus.
    Patra JC; Singh O
    J Comput Chem; 2009 Nov; 30(15):2494-508. PubMed ID: 19373836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein structure-based de novo design and synthesis of aldose reductase inhibitors.
    Iwata Y; Naito S; Itai A; Miyamoto S
    Drug Des Discov; 2001; 17(4):349-59. PubMed ID: 11765138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Robust cross-validation of linear regression QSAR models.
    Konovalov DA; Llewellyn LE; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Oct; 48(10):2081-94. PubMed ID: 18826208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
    Leonard JT; Roy K
    Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.